NPI: 1134546575 · HENDERSON, NV 89052 · Urgent Care Clinic/Center · NPI assigned 03/24/2014
Authorized official HOWORTH, WILLIAM controls 20+ related entities in our dataset. Read more
| Authorized Official | HOWORTH, WILLIAM (PRESIDENT, URGENT CARE) |
| NPI Enumeration Date | 03/24/2014 |
Other providers sharing the same authorized official: HOWORTH, WILLIAM
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 53,436 | $2.83M |
| 2019 | 95,908 | $5.24M |
| 2020 | 91,415 | $4.48M |
| 2021 | 109,740 | $5.91M |
| 2022 | 131,817 | $6.18M |
| 2023 | 112,967 | $5.84M |
| 2024 | 67,190 | $4.34M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 208,174 | 179,746 | $15.55M |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 86,310 | 74,493 | $6.08M |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 58,921 | 51,788 | $5.54M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 69,234 | 61,928 | $4.56M |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 54,143 | 47,833 | $910K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 11,988 | 10,342 | $661K |
| 87428 | 31,380 | 27,493 | $433K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 10,956 | 9,856 | $284K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 57,907 | 25,259 | $256K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 44,815 | 39,274 | $157K |
| 99215 | Prolong outpt/office vis | 791 | 758 | $84K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 6,717 | 5,986 | $81K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1,906 | 1,641 | $57K |
| 99205 | Prolong outpt/office vis | 379 | 354 | $48K |
| S9083 | Global fee urgent care centers | 1,182 | 1,116 | $22K |
| 99201 | 354 | 299 | $15K | |
| 71046 | Radiologic examination, chest; 2 views | 909 | 844 | $14K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1,473 | 1,323 | $13K |
| 81025 | 2,836 | 2,626 | $9K | |
| 73610 | 370 | 352 | $7K | |
| 73630 | 400 | 377 | $7K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 918 | 862 | $4K |
| 93000 | 315 | 307 | $3K | |
| 73130 | 170 | 155 | $3K | |
| 81003 | 2,188 | 2,008 | $2K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 914 | 884 | $2K |
| 73110 | 86 | 78 | $2K | |
| 69209 | 195 | 177 | $1K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,436 | 1,289 | $1K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 29 | 29 | $805.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 130 | 121 | $754.99 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | 264 | 257 | $657.54 |
| 73140 | 39 | 35 | $597.58 | |
| 73562 | 19 | 15 | $299.00 | |
| A6449 | Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard | 343 | 318 | $257.16 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | 588 | 520 | $185.47 |
| 74018 | 20 | 17 | $104.50 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 101 | 98 | $33.35 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 14 | 13 | $18.77 |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 60 | 47 | $12.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 16 | 16 | $1.01 |
| A9150 | Non-prescription drugs | 257 | 243 | $0.07 |
| 99051 | 29 | 28 | $0.00 | |
| 99000 | 3,181 | 2,745 | $0.00 | |
| S8110 | Peak expiratory flow rate (physician services) | 16 | 14 | $0.00 |